The role of inflammatory resolution in cardiometabolic health and disease

2019-01-14

Asst. Prof. Emma Börgeson

Wallenberg Centre for Molecular and Translational Medicine, 
University of Gothenburg

Tuesday, January 15,
13:15   BMC C2:305


Cardiometabolic disease is driven by inflammation, particularly in the adipose tissue. Inflammation consists of the initial acute phase, followed by a resolving phase. Importantly, the latter is regulated by specialized pro-resolving lipid mediators, e.g. the lipoxins, acting through defined receptors. Our research focuses on the investigation of specialized pro-resolving lipid mediators, such as the lipoxins, and their ability to promote cardiometabolic health in obesity.

Host:  Gustaf Christoffersson and Mia Phillipson